Becker's Healthcare May 3, 2024
Delayed gastric emptying, also known as gastroparesis, is a more common side effect of GLP-1s than other diabetes and weight loss treatments, according to new research.
Gastroparesis can range from mild symptoms to severe side effects, including refractory symptoms, the inability to orally consume nutrition and frequent hospital admissions. The most severe cases are known as stomach paralysis, and gastrointestinal clinicians have noticed a connection between the condition and GLP-1s.
GLP-1s, or glucagon-like peptide-1 receptor agonists, are a drug class that helps diminish appetite and create a feeling of fullness. Most GLP-1 medications are approved for Type 2 diabetes, with a few indicated for chronic weight management and serious cardiovascular problems.
In mid-2023, amid the increasing popularity of...
Today's Sponsors
Today's Sponsor